A Protocol for Active Surveillance of Acute Myocardial Infarction in Association with the use of a New Antidiabetic Pharmaceutical Agent

    Basic Details
    Date
    Thursday, January 19, 2012
    Type
    Publication
    Medical Product
    oral antidiabetic medication
    saxagliptin
    Health Outcome(s)
    acute myocardial infarction (AMI)
    Description

    This article describes a protocol for active surveillance of acute myocardial infarction (AMI) in users of a recently approved oral antidiabetic medication, saxagliptin, along with several comparators, and provides the rationale for decisions made in drafting the protocol.

    Author(s)

    Bruce Fireman MA; Sengwee Toh ScD; Melissa G. Butler PharmD, PhD, MPH; Alan S. Go MD; Hylton V. Joffe MD, MMSc; David J. Graham MD, MPH; Jennifer C. Nelson PhD; Gregory W. Daniel PhD, MPH, RPH; Joe V. Selby MD, MPH

    Corresponding Author

    Bruce Fireman, Division of Research, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612, USA. E-mail: bruce.fireman@kp.org